Insider Transactions in Q4 2025 at Age X Therapeutics, Inc. (AGE)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 23
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,100
-100.0%
|
$8,200
$2.6 P/Share
|
|
Dec 23
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,100
+50.0%
|
$0
$0.06 P/Share
|
|
Dec 22
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,673
-100.0%
|
$11,346
$2.67 P/Share
|
|
Dec 22
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,673
+50.0%
|
$0
$0.06 P/Share
|
|
Dec 16
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,227
-100.0%
|
$6,454
$2.96 P/Share
|
|
Dec 16
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,227
+50.0%
|
$0
$0.06 P/Share
|
|
Dec 12
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,700
-100.0%
|
$5,100
$3.26 P/Share
|
|
Dec 12
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,700
+50.0%
|
$0
$0.06 P/Share
|
|
Dec 11
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,555
-100.0%
|
$10,665
$3.24 P/Share
|
|
Dec 11
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,555
+50.0%
|
$0
$0.06 P/Share
|
|
Dec 10
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
645
-100.0%
|
$1,935
$3.35 P/Share
|
|
Dec 10
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
645
+50.0%
|
$0
$0.06 P/Share
|
|
Dec 09
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
600
-100.0%
|
$1,800
$3.31 P/Share
|
|
Dec 09
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
600
+50.0%
|
$0
$0.06 P/Share
|
|
Dec 03
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$15,000
$3.52 P/Share
|
|
Dec 03
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$0
$0.06 P/Share
|
|
Dec 02
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,500
-100.0%
|
$4,500
$3.91 P/Share
|
|
Dec 02
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+50.0%
|
$0
$0.06 P/Share
|
|
Nov 25
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,965
-50.0%
|
$17,895
$3.9 P/Share
|
|
Nov 25
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,965
+33.33%
|
$0
$0.06 P/Share
|
|
Nov 24
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
535
-100.0%
|
$1,605
$3.94 P/Share
|
|
Nov 24
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
535
+50.0%
|
$0
$0.06 P/Share
|
|
Nov 18
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,500
-100.0%
|
$19,500
$3.75 P/Share
|
|
Nov 18
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+50.0%
|
$0
$0.06 P/Share
|
|
Nov 10
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,500
-100.0%
|
$26,000
$4.1 P/Share
|
|
Nov 10
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+50.0%
|
$0
$0.06 P/Share
|
|
Nov 05
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,398
-100.0%
|
$13,592
$4.24 P/Share
|
|
Nov 05
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,398
+50.0%
|
$0
$0.06 P/Share
|
|
Nov 04
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,102
-100.0%
|
$12,408
$4.4 P/Share
|
|
Nov 04
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,102
+50.0%
|
$0
$0.06 P/Share
|
|
Oct 28
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,551
-100.0%
|
$22,204
$4.96 P/Share
|
|
Oct 28
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,551
+50.0%
|
$0
$0.06 P/Share
|
|
Oct 27
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
949
-100.0%
|
$4,745
$5.19 P/Share
|
|
Oct 27
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
949
+50.0%
|
$0
$0.06 P/Share
|
|
Oct 20
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,500
-100.0%
|
$26,000
$4.97 P/Share
|
|
Oct 20
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+50.0%
|
$0
$0.06 P/Share
|
|
Oct 13
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,326
-100.0%
|
$21,630
$5.2 P/Share
|
|
Oct 13
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,326
+50.0%
|
$0
$0.06 P/Share
|